To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Long bone fractures: Addition of midazolam to morphine does not improve pain relief

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
November 2013

Long bone fractures: Addition of midazolam to morphine does not improve pain relief

Vol: 2| Issue: 10| Number:7| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Comparison of a morphine and midazolam combination with morphine alone for paediatric displaced fractures: a randomized study

Acta Paediatr. 2011 Nov;100(11):e203-7. doi: 10.1111/j.1651-2227.2011.02311.x. Epub 2011 May 11

Contributing Authors:
C Wille-Ledon H Chappuy C Giraud JM Treluyer G Cheron

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

58 children with long-bone fractures were randomized to either receive oral morphine combined with sublingual midazolam or morphine combined with sublingual placebo, to determine which combination of drugs best alleviated pain. At 120 minutes after drug administration, there were no significant differences between patients who received morphine alone or morphine combined with midazolam.

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue